Abstract
Meningioma is a common primary brain tumor in adults. The treatment approach depends on its grade, size and symptoms. The case reported here was a repeatedly recurring transitional meningioma, previously treated with several surgical procedures and two sessions of cranial radiosurgery. At the time of last relapse, temozolomide was administered alone and combined with external beam radiation therapy. At the last follow-up after 38 months, the disease was stable. In conclusion, in this case of plurirecurrent meningioma, treatment with temozolomide alone and in combination with radiotherapy was feasible and associated with limited morbidity, providing clinical benefit and long local disease control. We discuss the case comparing our approach with other experiences reported in the literature.
MeSH terms
-
Adult
-
Antineoplastic Agents, Alkylating / therapeutic use*
-
Brain Neoplasms / diagnosis*
-
Brain Neoplasms / drug therapy
-
Brain Neoplasms / radiotherapy
-
Brain Neoplasms / surgery
-
Brain Neoplasms / therapy*
-
Chemotherapy, Adjuvant
-
Craniotomy
-
Dacarbazine / analogs & derivatives*
-
Dacarbazine / therapeutic use
-
Dose Fractionation, Radiation
-
Female
-
Headache / etiology
-
Humans
-
Magnetic Resonance Imaging
-
Meningeal Neoplasms / diagnosis*
-
Meningeal Neoplasms / drug therapy
-
Meningeal Neoplasms / radiotherapy
-
Meningeal Neoplasms / surgery
-
Meningeal Neoplasms / therapy*
-
Meningioma / diagnosis*
-
Meningioma / drug therapy
-
Meningioma / radiotherapy
-
Meningioma / surgery
-
Meningioma / therapy*
-
Neoplasm Recurrence, Local / diagnosis*
-
Neoplasm Recurrence, Local / drug therapy
-
Neoplasm Recurrence, Local / radiotherapy
-
Neoplasm Recurrence, Local / surgery
-
Neoplasm Recurrence, Local / therapy*
-
Pregnancy
-
Pregnancy Complications, Neoplastic / diagnosis
-
Pregnancy Complications, Neoplastic / therapy
-
Radiosurgery*
-
Radiotherapy, Adjuvant
-
Sleep Stages
-
Temozolomide
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Alkylating
-
Dacarbazine
-
Temozolomide